This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Bendectin trial widens as study questioned in court
In Cincinnati AP reports Dr. Alan Done argues Merrell Dow's Bendectin safety study is flawed and inconclusive. The cross examination of four hours centers on alleged data that may undermine the drug's claimed safety for 18 million U.S. users. The judge presides over more than 1,000 consolidated birth defect lawsuits while British plaintiffs seek access to legal action abroad and face contingency-fee limitations.
MENTIONED IN THIS ARTICLE
Cincinnati
Alan Done
Merrell Dow Pharmaceuticals
Frank C. Woodside III
U.S
Carl B. Rubin
Merrell Dow
Woodside
Done
Barry
Shirley Hall
Derby
England
Rubin
Hannah
Hall
Britain
United States